Pleuroparenchymal Fibroelastosis as a Late-Onset Pulmonary Toxicity after Treatment with Anticancer Chemotherapy for High-Risk Neuroblastoma
Pleuroparenchymal fibroelastosis (PPFE) is a rare, progressive, restrictive lung disease characterized by hypercarbic respiratory failure. In pediatrics, it has been described in patients with a history of malignancy who have received a bone marrow transplant, chemotherapy, or radiotherapy. It is ch...
Saved in:
Main Authors: | Satoshi Yokoyama, Risa Kanai, Daisuke Fukao, Keigo Hamahata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2024/4352032 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pleuroparenchymal Fibroelastosis: A New Entity within the Spectrum of Rare Idiopathic Interstitial Pneumonias
by: Karina Portillo, et al.
Published: (2015-01-01) -
Blasting neuroblastoma using optimal control of chemotherapy
by: Craig Collins, et al.
Published: (2009-05-01) -
Pleuroparenchymal Lung Disease Secondary to Nonoccupational Exposure to Vermiculite
by: Fahad Al-Ghimlas, et al.
Published: (2007-01-01) -
Immediate Response to Chemotherapy in an Adult Neuroblastoma Patient Presenting with Cord Compression
by: Nedal Bukhari, et al.
Published: (2020-01-01) -
Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy
by: Y. Maor, et al.
Published: (2013-01-01)